P4O GER Week ended 07 Aug 2026

Weekly Investor Report

Planoptik AG · Technology · Scientific & Technical Instruments

Open interactive chart View report data
Latest close 8.14 EUR
9.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is 2.5% above the Trend Line and sits at 37.1% of its 52-week range. The latest completed week returned 9.4%, after a -6.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 36 out of 100
Latest Close 8.14 EUR 7 Aug 2026
1W Return 9.4% latest completed week
4W Return -6.9% short-term follow-through
12W Return -36.2% quarterly tape
Trend Breadth 98.1% 51 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 43.72% based on similar historical setup states.
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 9.4% Latest completed week; four-week move -6.9%. Indicator stack 54/27 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.72% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 0 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 2.5% above the Trend Line and sits at 37.1% of its 52-week range. The latest completed week returned 9.4%, after a -6.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5712-week average 0.82

12-week confirmation

Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.57Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -6.9% over four weeks, -36.2% over 12 weeks, and 95.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W9.4%
4W-6.9%
12W-36.2%
26W62.8%
52W95.7%
Active trend streak0 weeks
Active weeks in one year51
Trend breadth98.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.98Latest activity-pressure read.
Pressure change-68.8%Four-week change in activity pressure.
Leadership18.06Latest relative-leadership reading.
RS change-52.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 82% Model confidence 65%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength22/100Blend of value, momentum, and quality. Underlying universe rank 79; rank 1 is best.
Value19/100Relative valuation strength. Underlying universe rank 82; rank 1 is best.
Quality21/100Profitability and accounting quality. Underlying universe rank 80; rank 1 is best.
Momentum93/100Medium-term price momentum. Underlying universe rank 8; rank 1 is best.
Growth24/100Revenue and earnings growth. Underlying universe rank 77; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
3.3x
Market value relative to trailing revenue.
EV / EBITDA
22.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-3.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
87.9%
Gross profit retained from each unit of revenue.
Operating margin
-0.8%
Operating profit retained from revenue.
Free-cash-flow margin
-10.5%
Free cash flow generated from revenue.
Return on invested capital
-0.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-4.9%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-160.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 0 relevant articles.

0 positive · 0 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-49.1%Distance below the 52-week high.
13-week volatility17.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+45.7%Week of 29 May.
Worst week-26.4%Week of 1 May.
Latest week+9.4%Week of 7 Aug.

Shape of recent returns

Strong gains10
Modest gains3
Flat weeks0
Modest losses2
Sharp losses11
Recent vol17.2%13-week weekly-return volatility.
Base vol13.9%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew12.3% / -6.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryDE Scientific & Technical Instruments
4-week rank3 / 3
Group average0.7%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD0.0%positive activity pressure
RS100.0%positive relative leadership

Four-week leaders

M7U · GER5.0%V6C · GER3.9%P4O · GER-6.9%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape43/100

Trend, activity pressure, participation, and risk combine to a 43/100 tape read.

 Indicator analysis65/100

Latest 12-week confirmation: trend 11/12, activity pressure 5/12, relative leadership 12/12.

Activity pressure 0.57; 2 reversal markers Next-Week ExpectancyNegative 43.72%

Next-week expectancy is negative with a 43.72% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors35/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 75; Small Cap Core rank 92 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 0 relevant articles.

 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20268.14 EUR9.4%7.95 EUR4.51 EUR-0.9818.0643.9KOff
31 Jul 20267.44 EUR-2.1%7.85 EUR4.48 EUR-0.9611.9468.6KOn
24 Jul 20267.60 EUR-5.5%7.76 EUR4.46 EUR-0.8817.6267.6KOn
17 Jul 20268.04 EUR-8.0%7.66 EUR4.45 EUR-0.7526.9656.0KOn
10 Jul 20268.74 EUR-5.8%7.53 EUR4.42 EUR-0.5838.2476.4KOn
3 Jul 20269.28 EUR0.7%7.39 EUR4.40 EUR-0.3944.774.7KOn
26 Jun 20269.22 EUR0.2%7.23 EUR4.37 EUR-0.1152.8415.6KOn
19 Jun 20269.20 EUR-7.1%7.05 EUR4.34 EUR0.4453.389.2KOn
12 Jun 20269.90 EUR-12.4%6.88 EUR4.31 EUR0.7070.5125.7KOn
5 Jun 202611.30 EUR-21.5%6.69 EUR4.29 EUR1.1497.9312.4KOn
29 May 202614.40 EUR45.7%6.45 EUR4.25 EUR1.43155.57421.4KOn
22 May 20269.88 EUR-22.5%6.12 EUR4.18 EUR1.1983.80193.5KOn
15 May 202612.75 EUR18.6%5.93 EUR4.14 EUR1.52152.34412.5KOn
8 May 202610.75 EUR36.4%5.65 EUR4.09 EUR1.59117.26252.4KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context